Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastrointestinal Neoplasms × ulixertinib × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Uveal Melanoma 1 Neoplasms 1 Melanoma 1 Histiocytic Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 16 Surveys and Questionnaires 15 Fluorouracil 14 Leucovorin 12 Capecitabine 11 Irinotecan 10 Blood Specimen Collection 8 Standard of Care 6 Endoscopic Mucosal Resection 6 Cisplatin 6 atezolizumab 5 Educational Status 5 Drug Therapy 5 S 1 (combination) 4 Radiotherapy 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Gemcitabine 4 Everolimus 4 Docetaxel 4 Bevacizumab 4 tegafur-gimeracil-oteracil 3 pemigatinib 3 apatinib 3 Remote Patient Monitoring 3 Quality of Life 3 Nivolumab 3 Diet Therapy 3 Colonoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04145297 2024-11-18

UTAH

University of Utah

Phase 1 Completed

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡